baber/WOPTO huggingface dataset:
Patent PE-20020099-Z (PE)
Title: Dispositivo de cierre para arqueta de registro
Inventor: MARTINEZ NAVARRETE MAXIMINO
IPC: E02D29/12
Filed: 2001-07-19
Abstract: QUE COMPRENDE: 1) UN MARCO FIJADO A UNA ARQUETA EN CORRESPONDENCIA CON UNA BOCA DE ACCESO; 2) UNA TAPA ASENTADA SOBRE UN ALA INTERNA DE DICHO MARCO CON INTERPOSICION DE UNA JUNTA DE ESTANQUEIDAD QUE INCLUYE UN PLANO SUPERIOR INCLINADO PERIMETRAL QUE DESCIENDE HACIA EL INTERIOR DONDE ASIENTA COMPLEMENTARIAMENTE UNA BANDA PERIMETRAL INFERIOR DE UNA TAPA CON LA MISMA INCLINACION PARA ALCANZAR UN CIERRE PROGRESIVO EN FUNCION DEL APRIETE DE (2) A TRAVES DE UN TORNILLO CENTRAL; 3) UN TRAVESANO ASOCIADO A (1) MEDIANTE UNAS PROLONGACIONES EXTREMAS DE DICHO (1), DONDE SE ACOPLA UN TORNILLO DE APRIETE A TRAVES DE UN ORIFICIO CENTRAL DE (2) PARA SER FIJADO CONTRA LA JUNTA DE ESTANQUEIDAD; Y 4) MEDIOS DE RETENCION DEL TRAVESANO
Patent ES-490799-A0 (ES)
IPC: C07D233/88
Filed: 1980-04-23
Abstract: 1. Process for the manufacture of imidazolidine derivatives of the general formula  see diagramm : EP0017976,P9,F1  wherein X represents imino or oxygen and R represents one of the groups  see diagramm : EP0017976,P9,F2  characterized by reacting a compound of the general formula R-NH-R**4 with a compound of the general formula  see diagramm : EP0017976,P9,F3  whereby in formulae II and III the one R**4 signifies hydrogen and the other R**4 signifies a COOR**5 group, wherein R**5 represents optionally substituted phenyl, and R signifies the same as above, to a compound of the general formula see diagramm : EP0017976,P9,F4  wherein R signifies the same as above, and, if desired, hydrolyzing the latter compound to a hydantoin compound of the general formula  see diagramm : EP0017976,P9,F5  wherein R signifies the same as above.
Patent ES-499321-A0 (ES)
IPC: B32B15/08
Filed: 1981-02-11
Abstract: The composite structure, which has a reflectivity of at least 85%, a heat-emission of about 8% of the Stefan-Boltzmann constant at 23 DEG C, a mirror reflectivity (as defined) of at least 4 and dead fold properties the same as the substrate, is prepared by coating a smooth polymeric film (1) with a lacquer (2) which gives a releasable bond to the film and has a contact angle of zero degrees to the film, vapour depositing a metal layer (3) on the lacquer to produce a non-releasable bond, applying a laminating adhesive (6) to the metal layer (3) and bonding by means of the laminating adhesive (6) to a non-metallic substrate (7) and stripping the polymer film (1) from the lacquer layer (2).
Patent ES-504391-A0 (ES)
IPC: G11B7/08
Filed: 1981-07-29
Abstract: By means of a radiation beam, an apparatus writes or reads information on an information surface of a rotary optical information disc (21), which apparatus comprises an objective frame (16) on which an objective (17) for concentrating the radiation beam to a radiation spot is mounted by means of a parallel guide (19) in such a way that it can move in the direction of its optical axis (18). The objective is protected against dust, contaminants and mechanical damage by means of stationary plane-parallel radiation-transparent shielding means (22), which are interposed between the objective and the rotary information disc, the lens system of the objective being corrected for the optical properties of the shielding means.
Patent ES-520193-A0 (ES)
IPC: C07D207/09
Filed: 1983-03-01
Abstract: Novel therapeutically active compounds of the formula   <IMAGE> I wherein R1 and R2 are the same or different and each represents a hydrogen atom, a halogen atom, a cyano group, a lower alkyl group or an acyl group, R3 is a lower alkyl group; an alkenyl group; or a benzyl group optionally substituted with fluorine, chlorine, bromine, trifluoromethyl, lower alkyl or lower alkoxy, A1 and A2 are the same or different and each represents a hydrogen atom, a lower alkyl group, an acyl group, an alkoxycarbonyl group or a dialkylcarbamyl group, provided that when A1 and A2 are the same lower alkyl group and R3 is ethyl, R1 or R2 or both are selected among cyano, lower alkyl and acyl; or a physiologically acceptable salt or optical isomers thereof, methods for their preparation, pharmaceutical preparations containing the compounds and methods for their therapeutical use.
Patent ES-523729-A0 (ES)
IPC: H01M6/18
Filed: 1983-06-30
Abstract: Anode composition based on a mixture of plastic or elastomeric macromolecular material with ionic conduction, an alloy of lithium and particles of a carbon compound of the formula: LixC where 0</=x<0.3. Anodes so constituted, as well as electrochemical generators with solid electrolytes comprising these anodes. Better utilization of the lithium of the materials of the electrodes.
Patent ES-546536-A0 (ES)
IPC: C12Q1/68
Filed: 1985-08-29
Abstract: Described is a genetic analyses using the technique of nucleic acid hybridization. The genetic analyses includes, for example, the diagnosis of infections by foreign microbes and the detection of specific genetic traits and abnormalities. Furthermore, a technique for the detection of the presence of a polynucleotide sequence of interest is described.
Patent ES-554085-A0 (ES)
IPC: H04N5/913
Filed: 1986-04-17
Abstract: A video signal is modified so that a television receiver will still provide a normal color picture from the modified video signal while a videotape recording of the modified video signal produces generally unacceptable pictures. This invention relies on the fact that typical videocassette recorder automatic gain control systems cannot distinguish between the normal sync pulses (including equalizing or broad pulses) of a conventional video signal and added pseudo-sync pulses. Pseudo-sync pulses are defined here as any other pulses which extend down to a normal sync tip level and which have a duration of at least 0.5 microseconds. A plurality of such pseudo-sync pulses is added to the conventional video signal during the vertical blanking interval, and each of such pseudo-sync pulses is followed by a positive pulse of suitable amplitude and duration. As a result, the automatic gain control system in a videotape recorder will make a false measurement of video level which causes an improper recording of the video signal. The result is unacceptable picture quality during playback. This approach utilizes positive-going pulses which occur at a time not ordinarily used for black-level restoration in typical television receivers, and therefore does not give rise to black level depression in such typical television sets.
Patent FI-852356-A0 (FI)
Inventor: VOELKER THEODOR
IPC: C08G18/32
Filed: 1985-06-13
Abstract: 1. Chain lengthening or cross-linking agent for polyurethanes and epoxy resins, consisting of 2,6,2',6'-tetraethyl-p,p'-methylene-bis-aniline, 2,6,2'-triethyl-6'-chloro-p,p'-methylene-bis-aniline and 2,2'-dichloro-6,6'-diethyl-p,p'-methylene-bis-aniline.
Patent FI-861008-A0 (FI)
Inventor: LENKE MICHAEL
IPC: A01G7/00
Filed: 1986-03-11
Abstract: For culturing a plant so as to have a dwaft habit the plant is placed in cavity inside a pot made of porous material, as for example clay. The plant pot is placed in an outer vessel, preferably with a gap therebetween for water or nutrient solution. Slot-like blind channels extend horizontally into the side wall of the plant pot and/or downwards into the bottom thereof. These channels serve as traps for roots of the tangled mass of roots in the cavity so that the growth of such roots is halted and they only put out root hairs in the channels. The check in the growth of the roots of the plant causes a permanently dwarfed habit.
Patent FI-874475-A0 (FI)
Inventor: ASBRINK LEIF
IPC: G08B13/24
Filed: 1987-10-12
Abstract: An alarm device, comprising a so-called alarm tag consist­ing of two parts arranged so as to be placeable each on one side of an article, for example an article of cloth­ing, of fur or other article, where a needle (6,7) is provided to extend from one part through the article to the second part, which alarm tag comprises devices for receiving a magnetic alternating field emitted to the alarm tag.The alarm tag (1) comprises devices (8,9,11,12) capable to emit an acoustic signal when the parts (2,3) of the alarm tag (1) move away from each other when the alarm tag (1) is put in a first, active, state and not emit an acoustic signal when the parts (2,3) of the alarm tag (1) move away from each other when the alarm tag (1) is put in a second, inactive, state.
Patent FI-882738-A0 (FI)
Inventor: WRETLIND KARL ARVID JOHANNES
IPC: A61K49/04
Filed: 1988-06-09
Abstract: The invention relates to an emulsion for use as an X-ray contrast agent and containing one or more iodinated lipids emulsified in an aqueous phase. The emulsion contains one or more amino acids, fatty acids or their salts, fat-soluble vitamins and/or urea for increasing its stability. Furthermore, the emulsion may contain one or more pharmacologically acceptable oils or fats. By the stability-increasing agents, it has been possible to prepare emulsions of iodinated lipids which can be sterilized in an autoclave and be stored for a long time without the emulsion breaking.
Patent FI-885128-A0 (FI)
Inventor: KISE MASAHIRO
IPC: C07D513/04
Filed: 1988-11-07
Abstract: Quinolinecarboxylic acid derivative represented by the following general formula (I) and physiologicallyacceptable salt thereof: <CHEM> in which R<1> is hydrogen, alkyl or substituted or unsubstituted phenyl; R<2> is hydrogen or alkyl; and R<3> is hydrogen, halogen or alkoxy. These compounds exhibit antibacterial activity and are useful as remedies for various infectious diseases.
Patent FI-885623-A0 (FI)
Inventor: BAYLIS ERIC KEITH
IPC: A61P39/02
Filed: 1988-12-02
Abstract: Compounds of the formula I <CHEM> wherein R denotes an aliphatic, cycloaliphatic, cycloaliphatic-aliphatic or araliphatic radical having 2 or more carbon atoms, and wherein one of the groups R<1>, R<2> and R<3> represents hydrogen or an aliphatic, cycloaliphatic, araliphatic or aromatic radical, another one of R<1>, R<2> and R<3> is hydrogen or, in the case of R<1> and R<2>, is hydroxy, and the remaining one of R<1>, R<2> and R<3> is hydrogen, and their salts have GABAB-antagonistic properties and can be used as GABAB-antagonists. They are obtained when in a compound of formula II <CHEM> in which R, R<1>, R<2> and R<3> have their previous significances, Z represents -NH2 and R<4> denotes a hydroxy-protective group R<5> or, when R<1> and R<3> denote hydrogen and R<2> denotes hydrogen or alkyl, denotes an alkali metal or ammonium ion R<6>, or Z represents a protected or latent amino group Z<0> and R<4> denotes hydrogen or a hydroxy-protective group R<5>, any group R<5> or R<6> is replaced by hydrogen, and/or any group Z<0> is converted into -NH2.
Patent FI-891832-A0 (FI)
Inventor: BOECK AUGUST
IPC: C12N1/20
Filed: 1989-04-18
Abstract: The invention relates to Escherichia coli strains for extensive protein secretion into the culture medium, to a process for the preparation of the said strains and to the use thereof. <IMAGE>
Patent FI-894587-A0 (FI)
Inventor: ALMHEM ROLF
IPC: B65G15/36
Filed: 1989-09-27
Abstract: A known conveyor belt, which is endless and runs over support rolls and turning rolls for the transportation of relatively light objects, consists of a woven fabric made of longitudinal filaments (1, 2) and cross-wise monofilaments. Such a conveyor belt is improved and offers a better runability and wear resistance by that at least the cross-wise filaments consists of flat or oval yarns (3) or yarns formed in a different way, where the ratio between width and height of the cross-section is at least 1.5.
Patent FI-900769-A0 (FI)
Inventor: MARDON PHILIPPE
IPC: G07F17/12
Filed: 1990-02-15
Abstract: The present invention relates to a storage system with adjacent lockers. The system is characterised in that it comprises, connected to a microprocessor-based device (4), a keyboard/display screen assembly (14) enabling an operator to record the identity of a user; a device (15) for supplying the user with a ticket on which are stored at least the number of the locker allocated to the user and the identity thereof; and a device (18) for receiving and reading the ticket (16) associated with each locker (2). The system finds application in stations or airports. <IMAGE>
Patent FI-901096-A0 (FI)
Inventor: BOSIES ELMAR
IPC: C07F9/10
Filed: 1990-03-02
Abstract: 3-(C16-C18)Alkanesulphinyl- and sulphonyl-2-methoxymethylpropyl (2-trimethylammonioethyl)phosphates, their pharmacologically acceptable salts, process for their preparation and medicaments having antitumour action containing these compounds.
Patent FI-913594-A0 (FI)
Inventor: BYERSMITH MICHAEL ROBERT
IPC: A47C1/124
Filed: 1991-07-26
Abstract: A chaise lounge recliner chair (300) which incorporates an intermediate leg support member (312) for providing support to the thighs and areas behind the knees of the legs of an occupant of the chair. The intermediate leg support member (312) is connected to a portion of the seat (306) of the recliner chair and a portion of the leg rest member (310) of the chair. When the leg rest member (310) is in an extended position the intermediate leg support member (312) provides a normal slightly convex support surface. As the seat back (302) of the chair is reclined, it causes the seat member (306) to be extended outwardly which causes the intermediate leg support member (312) to assume a pronounced convex surface. A plurality of elastic straps (324) are further included and disposed between the seat (306) and leg rest members (310) to prevent the intermediate leg rest member (312) from crowning downwardly relative to the chair frame when the leg rest member (310) is in it extended position. <IMAGE>
Patent FI-915913-A0 (FI)
Inventor: BENNINK HERMAN JAN TIJMEN COEL
IPC: A61K31/565
Filed: 1991-12-16
Abstract: Disclosed is an oral contraceptive regimen containing daily dosage units each containing from 70 to 80 micrograms of desogestrel, 3-ketodesogestrel or mixtures thereof. It has been found that by making a selection of desogestrel or 3-ketodesogestrel at the described dosages in an oral contraceptive regimen administered over the entire menstrual cycle (e.g. 28 days), effective ovulation inhibition is achieved and intermenstrual bleeding is avoided, while acceptable cycle control is retained. Moreover, the regimen also prevents the formation of persistent ovarian cysts.
Patent FI-922859-A0 (FI)
Inventor: CASTELLA SOLA JAUME
IPC: C07C25/24
Filed: 1992-06-18
Abstract: The invention relates to a process for the dehydrochlorination of 1,1-bis(R-phenyl)-2,2,2-trichloroethanes using an aqueous alkaline hydroxide solution, characterised in that the process is carried out in the absence of solvent and in the presence of a phase transfer agent.
Patent FI-951300-A0 (FI)
Inventor: ANDRIEU VERONIQUE
IPC: A61K9/50
Filed: 1995-03-20
Abstract: A pharmaceutical prepn. form for targeted release of alfuzosine chlorohydrate is new. The prepn. form comprises a core contg. the active ingredient surrounded by a coating contg. a pH-dependently-soluble polymer.
Patent FI-955771-A0 (FI)
Inventor: BAEHR ALBERT
IPC: B01D25/127
Filed: 1995-11-30
Abstract: In a process and assembly to de-water sludge (9) and similar substances, the sludge is charged into an enclosed main chamber (20) incorporating a filter surface (24, 25), and subjected to hydrostatic pressurisation. Following expulsion of the water, the chamber is opened and the filter cake removed on the filters (24, 25). The novelty is that before de-watering in the main chamber, the sludge charge is first held in an intermediate chamber (3), linked to the main chamber (20), whose inlet (6) is then blocked while the sludge is subjected to hydrostatic pressure which forces it into the main chamber (20). The incoming sludge is retained in a holding tank (5) until required for treatment.
Patent FI-956029-A0 (FI)
Inventor: BERLINER DAVID L
IPC: C07J1/00
Filed: 1995-12-14
Abstract: The invention relates to a method of altering hypothalamic function in an individual. The method comprises nasally administering a human semiochemical, e.g. an Androstane steroid, or a pharmaceutical composition containing a semiochemical, such that the ligand semiochemical binds to a specific neuroepithelial receptor. The steroid or steroids is/are preferably administered in the form of a pharmaceutical composition containing one or more pharmaceutically acceptable carriers. Other embodiments of the invention include pharmaceutical compositions containing the steroids.
Patent FI-972601-A0 (FI)
Inventor: LINGEMANN HORST
IPC: B21D51/00
Filed: 1997-06-18
Abstract: The hollow profiled metal bar, esp. made of aluminium is for use in double-glazing, and has a lengthwise weld seam (12a). The seam is formed in a retracted portion of the profile, where it is concealed. There can also be a second retracted portion (8b) on the opposite side of the bar, and which is a mirror image of the first one (8). The bar can have two parallel sidewalls (6), and two other walls (7) at right angles to them with the retracted portions form ed in them and running centrally in the lengthwise direction.
Patent IL-57651-A0 (IL)
Title: N-dicholoroacetyl-1,2,3,4-tetrahydro-quinaldine,its preparation and its use for preventing damage to crop plants by herbicicdes
IPC: A01N25/32
Filed: 1979-06-25
Abstract: 1. Claims for the contracting states : BE, CH, DE, FR, GB, IT, NL N-Dichloroacetyl-1,2,3,4-tetrahydro-quinaldine of the formula  see diagramm : EP0006540,P18,F2  1. Claims for the contracting state AT Process for the preparation of N-dichloroacetyl-1,2,3,4-tetrahydro-quinaldine of the formula  see diagramm : EP0006540,P19,F2  characterised in that 1,2,3,4-tetrahydro-quinaldine of the formula  see diagramm : EP0006540,P19,F4  is reacted with dichloroacetyl chloride, if appropriate in the presence of an acid-binding agent and if appropriate in the presence of a diluent.
Patent IL-57916-A0 (IL)
Title: N-substituted nitrogen-containing heterocyclic compounds,their preparation and pharmaceutical compositions containing them
IPC: A61K31/517
Filed: 1979-07-27
Abstract: Compounds of the formula   <IMAGE>   wherein Het is   <IMAGE>  +TR <IMAGE>  n is an integer from 1 to 4, inclusive, preferably 2 or 3, R1 is H or acyl, R2 is H, R1O, -NHSO2R7, -NHCOR8, -NHCONHR8, -NH-CH2-C6H4-R9, -CH2OH, -CH2SO2R7, -CONHR8, halogen or -CN, R3 is H, halogen, R7 or -OR7, R2 and R3 together with each other are <IMAGE>  R4 is H, -CH3 or -C2H5, R5 and R6 are each H or -CH3, R7 is C1-C4 alkyl, R8 is H or C1-C4 alkyl, R9 is H, C1-C4 alkyl or C1-C4 alkoxy optionally interrupted by oxygen, R10 and R12 are each H, CH3, Cl or OCH3, or together methylenedioxy, X is   <IMAGE>   or N, and Z is -CH2 or -CO; in the form of racemates, enantiomers, diastereoisomeric antipode pairs, and non-toxic, pharmacologically acceptable acid addition salts thereof. The compounds as well as the salts are useful as bronchospasmolytics, spasmolytics, muscle-relaxants, antiallergics and hypotensives.
Patent IL-61775-A0 (IL)
Title: Cephalosporin derivatives
IPC: C07D501/18
Filed: 1980-12-21
Abstract: A cephalosporin derivative of the formula: 
<CHEM>
 in which R<1> is any one of the C- 3 substituents from antibacterially-active cephalosporins known in the art; R<2> is any one of the C-4 substituents from antibacterially-active cephalosporins known in the art; R<3> is hydrogen, hydroxy, amino, C1-6alkyl, C1-6alkanoyl, C1-6alkoxy, C1-6alkonoylamino or C1-6alkylamino, phenylalkyl in which the alkyl part is C1-6 or phenyl in the latter two of which the phenyl is optionally substituted by methoxy:
 A< is a radical of the formula:- 
<CHEM>
 in which R<4> and R<5>, which may be the same or different are hydrogen, halogen, cyano, hydroxy, carboxy, pyridyl, C1-6alkyl, C1-6aminoalkyl, C1-6hydroxyalkyl, C2-6alkoxycarbonyl, C2-10alkylaminoalkyl, C3-15dialkylaminoalkyl, or phenyl optionally substitued by 1 or 2 radicals selected from halogen, nitro, amino, hydroxy, carboxy, cyano, C1-6alkyl and C2-6alkoxycarbonyl; or R<4> and R<5> are joined to form a mono-, bi- or tricyclic carbocyclic ring system which may be non-aromatic, partially aromatic or fully aromatic, the aromatic part being optionally substituted by 1, 2 or 3 radicals selected from halogen, hydroxy, amino, cyano, carboxy, carbamoyl, nitro, ureido, C1-6alkyl, C1-6alkoxy, C1-6haloalkyl, C1-6alkylamino, C1-6hydroxyalkyl, C1-6aminoalkyl, C1-6alkanoylamino and C1-6azidoalkyl, C2-8dialkylamino, C2-10alkylaminoalkyl, C3-15dialkylaminoalkyl, C2-6cyanoalkyl, C2-6carboxyalkyl, C2-6carbamoylalkyl, and
Patent IL-67087-A0 (IL)
Title: Compositions containing cysteine or homologues or derivatives thereof and method for increasing the growth and the harvest of plants
IPC: C05C11/00
Filed: 1982-10-27
Abstract: The addition of certain polyoxyethylated surfactants to biostimulating compositions for plants, containing cysteine or homologouses or reaction products thereof with aldehydes or derivatives of such products and pholic acid, imparts to the compositions an improved biostimulating activity which promotes the growth of the plants and the harvest yield.
Patent IL-73757-A0 (IL)
Title: Thiolane-2,4-dione-3-carboxamides,their preparation and their use as pesticides
IPC: C07D333/38
Filed: 1984-12-06
Abstract: Novel fungicidal active thiolane-2,4-dione-3-carboxamides of the formula   <IMAGE>   in which R is alkyl, cycloalkyl, optionally substituted aralkyl or optionally substituted aryl, and R1 and R2 each independently is hydrogen, alkyl, cycloalkyl, cycloalkylalkyl, aralkyl or aryl.
Patent IL-85403-A0 (IL)
Title: Thionophosphonic acid esters,their preparation and their use as pesticides
IPC: A01N57/24
Filed: 1988-02-11
Abstract: Arthropodicidally active O-(6-alkoxy-2-tert-butylpyrimidin-4-yl)-O-methyl-thionoethanephosphonic acid diesters of the formula   <IMAGE>   in which R represents alkyl with 1 to 4 carbon atoms or cycloalkyl with 3 or 4 carbon atoms. The intermediate where R is replaced by H is also new.
Patent IL-93862-A0 (IL)
Title: Enzymatic assay kit and method applicable to whole cells
IPC: G01N33/569
Filed: 1990-03-23
Abstract: The invention relates to a kit for determination of the endogenous cell enzymes characteristic of a cell population or subpopulation, comprising, as components: a) a solid support to which one or more monoclonal antibodies directed towards surface antigens of the cell population to be determined are bound by covalent bonding or by physical adsorption; b) one or more solutions supplying the necessary reagents (substrate and chromogen) for visualising the activity of the endogenous enzyme to be determined. The invention also relates to a method for enzymatic determination of the endogenous enzymes of a cell population or subpopulation. The kit for determination and the enzymatic method according to the invention may be used for the determination of myeloperoxidase in the granulocytes in the blood or urine.
Patent FI-20002670-A0 (FI)
Inventor: LAAMANEN HEIKKI
IPC: H04L27/227
Filed: 2000-12-05
Abstract: The invention relates to a method and apparatus for improving the quality of receiver synchronization on QAM- or CAP-modulated modem connections having an adaptive linear equalizer. The invention is based on the finding that in a QAM- or CAP-modulated data transmission system where the symbol rate and the average carrier frequency are in fixed relationship with each other, the vector formed by the In-phase and the Quadrature component of the detector input signal rotates with the timing phase shift of the receiver. The quality of receiver synchronization is improved by utilizing information extracted from the vector rotation.
Patent FI-20041287-A0 (FI)
Inventor: PAJALA MATTI
IPC: D21G1/02
Filed: 2004-10-04
Abstract: A roll is supported at the middle thereof, for a paper, board or finishing machine is composed of two sections, a so-called inner shell (54′) and an outer shell (52′), supported by one another in the middle area of the roll (50′). The nominal stiffness of the manufacturing material of the inner shell (54′) of the roll is substantially greater than the nominal stiffness of the manufacturing material of the outer shell (52′) of the roll.